Effect of Deferoxamine on Renal Fibrosis
Ikeda, Yasumasa The University of Tokushima Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Ozono, Iori The University of Tokushima
Tajima, Soichiro The University of Tokushima
Imao, Mizuki The University of Tokushima
Horinouchi, Yuya The University of Tokushima
Izawa-Ishizawa, Yuki The University of Tokushima Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Ishizawa, Keisuke The University of Tokushima Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Tsuchiya, Koichiro The University of Tokushima Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Tamaki, Toshiaki The University of Tokushima Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Renal fibrosis plays an important role in the onset and progression of chronic kidney diseases (CKD). Although several mechanisms underlying renal fibrosis and candidate drugs for its treatment have been identified, the effect of iron chelator on renal fibrosis remains unclear. In the present study, we examined the effect of an iron chelator, deferoxamine (DFO), on renal fibrosis in mice with surgically induced unilateral ureter obstruction (UUO). Mice were divided into 4 groups: UUO with vehicle, UUO with DFO, sham with vehicle, and sham with DFO. One week after surgery, augmented renal tubulointerstitial fibrosis and the expression of collagen I, III, and IV increased in mice with UUO; these changes were suppressed by DFO treatment. Similarly, UUO-induced macrophage infiltration of renal interstitial tubules was reduced in UUO mice treated with DFO. UUO-induced expression of inflammatory cytokines and extracellular matrix proteins was abrogated by DFO treatment. DFO inhibited the activation of the transforming growth factor-β1 (TGF-β1)-Smad3 pathway in UUO mice. UUO-induced NADPH oxidase activity and p22phox expression were attenuated by DFO. In the kidneys of UUO mice, divalent metal transporter 1, ferroportin, and ferritin expression was higher and transferrin receptor expression was lower than in sham-operated mice. Increased renal iron content was observed in UUO mice, which was reduced by DFO treatment. These results suggest that iron reduction by DFO prevents renal tubulointerstitial fibrosis by regulating TGF-β-Smad signaling, oxidative stress, and inflammatory responses.
© 2014 Ikeda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|DOI (Published Version)|
|URL ( Publisher's Version )|
pone_9_2_e89355.pdf 2.6 MB